SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals,...
VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production...
NEW YORK – May 9, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will participate in a fireside chat at the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day in New York City on Monday, May 15,...
Virtual event will take place on Friday, May 12, 2023 at 10 a.m. EST Register NEW YORK – May 4, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will host a virtual Key Opinion Leader (KOL) event on Friday,...
Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
